Skip to main content
SpringerLink
Log in

A Multilayered Research Framework for Humanities and Epidemiology of Medicinal Product Risk Communication

  • Chapter
  • First Online:
Communicating about Risks and Safe Use of Medicines

Abstract

Modern medicines are among the most successful health interventions, and as such are part of our daily lives and conversations. However, they do not come without risks, and safe use advice from healthcare professionals, conversations between friends and debates in the media are some of the many forms communication about risks with medicines can take. With a view to improving communication for the benefit of patients and society as a whole, this chapter discusses how to approach communication about medicine risks with curiosity and compassion for communication as a vital human behaviour and with consideration for the social spheres where such communication actually happens. Reflecting on past and current safety challenges with medicines, the chapter proposes a multilayered research framework that combines different data types and methods from various scientific disciplines to gain a wider and deeper understanding of the complexity of communication as well as the causal relationships, risk and success factors and pathways towards outcomes. This research approach advocates for the active participation of patients, healthcare professionals and journalists in research and mutual learning. It should generate evidence relevant for communicators in high- and low-income countries alike and prepare the ground for establishing a self-standing inclusive discipline of humanities and epidemiology of medicinal product risk communication.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abalkhail MS, Alzahrany MS, Alghamdi KA, Alsoliman MA, Alzahrani MA, Almosned BS, Gosadi IM, Tharkar S (2017) Uptake of influenza vaccination, awareness and its associated barriers among medical students of a University Hospital in Central Saudi Arabia. J Infect Public Health 10:644–648

    Article  PubMed  Google Scholar 

  • Ahlqvist-Radstad J, Andric A, Baldelli I, Buckley N, Coleman AM, Cupelli A, Escudero Y, Hearn J, Knudsen Y, Ángel MaciÁ M, Michan L, Montero D, Rodriguez A, Samdal H, Sipic I, Spooner A, Wennberg A (2016) SCOPE Work Package 6 survey report: patient and consumer consultation. Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) Joint Action. http://www.scopejointaction.eu. Accessed 29 Dec 2017

  • Akl EA, Oxman AD, Herrin J, Vist GE, Terrenato I, Sperati F, Costiniuk C, Blank D, Schünemann H (2011a) Framing of the health information message in either negative or positive words. Cochrane Database Syst Rev (12):CD006777

    Google Scholar 

  • Akl EA, Oxman AD, Herrin J, Vist GE, Terrenato I, Sperati F. Costiniuk C, Blank D, Schünemann H. Using alternative statistical formats for presenting risks and risk reductions. Cochrane Database Syst Rev. 2011b; 3: CD006776

    Google Scholar 

  • Aldoory L (2017) The status of health literacy research in health communication and opportunities for future scholarship. Health Commun 32:211–218

    Article  PubMed  Google Scholar 

  • Allport G (1935) Quoted in: Schwarz N and Bohner G (2001) The construction of attitudes. In: Tesser A and Schwarz N (eds) Intrapersonal processes (Blackwell Handbook of Social Psychology). Blackwell, Oxford, pp 436–457

    Google Scholar 

  • Anderson T (2017) Curbing prescription opioid dependency. Bull World Health Organ 95:318–319

    Article  Google Scholar 

  • Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, Lee BW, Lolekha S, Peltola H, Ruff TA, Santosham M, Schmitt HJ (2008) Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ 86:140–146

    Article  CAS  PubMed  Google Scholar 

  • Angamo MT, Chalmers L, Curtain CM, Bereznicki LRE (2016) Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Saf 39:847–857

    Article  CAS  PubMed  Google Scholar 

  • Anoko JN (2014) Communication with rebellious communities during an outbreak of Ebola Virus Disease in Guinea: an anthropological approach. Social Science for Emergency Response (online). http://www.ebola-anthropology.net/case_studies/communication-with-rebellious-communities-during-an-outbreak-of-ebola-virus-disease-in-guinea-an-anthropological-approach/. Accessed 18 June 2017

  • Aronson JK (2016) “Collaborative care” is preferable to “patient centred care”. Br J Med 253:i2926

    Article  Google Scholar 

  • Atkins R, Bluebond-Langner M, Read N, Pittsley J, Hart D (2010) Adolescents as health agents and consumers: results of a pilot study of the health and health-related behaviors of adolescents living in a high-poverty urban neighborhood. J Pediatr Nurs 25:382–392

    Article  PubMed  Google Scholar 

  • Aull F. Medical humanities. Medical Humanities Community, New York University School of Medicine, New York. Archived from the original on 18 May 2011. http://medhum.med.nyu.edu. Accessed 18 Jun 2017

  • Bahri P (2010) Public pharmacovigilance communication: a process calling for evidence-based, objective-driven strategies. Drug Saf 33:1065–1079

    Article  PubMed  Google Scholar 

  • Bahri P, Harrison-Woolrych M (2012) Focusing on risk communication about medicines: why now? [editorial]. Drug Saf 35:971–975

    Article  PubMed  PubMed Central  Google Scholar 

  • Bahri P, Dodoo AN, Edwards BD, Edwards IR, Fermont I, Hagemann U, Hartigan-Go K, Hugman B, Mol PG, on behalf of the ISoP CommSIG (2015) The ISoP CommSIG for improving medicinal product risk communication: a new special interest group of the International Society of Pharmacovigilance. Drug Saf 38:621–627

    Article  PubMed  Google Scholar 

  • Bahri P, Fogd J, Morales D, Kurz X (2017) ADVANCE consortium. Application of real-time global media monitoring and ‘derived questions’ for enhancing communication by regulatory bodies: the case of human papillomavirus vaccines. BMC Med 15:91

    Article  PubMed  PubMed Central  Google Scholar 

  • Bahri P, Rägo L, on behalf of the CIOMS Working Group on Vaccine Safety (2019) CIOMS guide to vaccine safety communication: executive summary. Vaccine 37:401–408

    Article  PubMed  Google Scholar 

  • Banerjee AK, Zomerdijk IM, Wooder S, Ingate S, Mayall SJ (2014) Post-approval evaluation of effectiveness of risk minimisation: methods, challenges and interpretation. Drug Saf 37:33–42

    Article  PubMed  Google Scholar 

  • BBC. A definition of information [archived webpage]. http://www.bbc.co.uk/schools/gcsebitesize/ict/databases/0datainforev2.shtml. Accessed 29 Dec 2017

  • Beck U (1986) Risikogesellschaft: Auf dem Weg in eine andere Moderne (Risk society: towards a new modernity). Suhrkamp, Frankfurt/Main

    Google Scholar 

  • Better Evaluation. Triangulation [webpage]. Updated on 19 Nov 2018. https://www.betterevaluation.org/en/evaluation-options/triangulation. Accessed 13 Mar 2019

  • Better Evaluation. Realist evaluation [webpage]. https://www.betterevaluation.org/en/approach/realist_evaluation. Accessed 6 June 2019

  • Birkbeck Centre for Medical Humanities. The language of illness and pain identity, communication and the clinical encounter [conference]. Birkbeck College, London; 2–3 July 2011

    Google Scholar 

  • Blendon RJ, Benson JM (2018) The public and the opioid-abuse epidemic. N Engl J Med 378:407–411

    Article  PubMed  Google Scholar 

  • Blendon RJ, Benson JM, Hero JO (2014) Public trust in physicians: US medicine in international perspective. N Engl J Med:371–317

    Google Scholar 

  • Boie K. Leseschwäche: Es ist zum Weinen. Zeit Online. 29 May 2018. https://www.zeit.de. Accessed 24 Mar 2019

  • Bongard V, Ménard-Taché S, Bagheri H, Kabiri K, Lapeyre-Mestre M, Montastruc JL (2002) Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals. Br J Clin Pharmacol 54:433–436

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Briesacher BA, Soumerai SB, Zhang F, Toh S, Andrade SE, Wagner JL, Shoaibi A, Gurwitz JH (2013) A critical review of methods to evaluate the impact of FDA regulatory actions. Pharmacoepidemiol Drug Saf 22:986–994

    PubMed  Google Scholar 

  • Bruns A. (2009) From prosumer to produser: understanding user-led content creation [presentation]. Transforming Audiences [conference], London; 3–4 September 2009

    Google Scholar 

  • Brynner R, Stephens T (2001) Dark remedy: the impact of thalidomide and its revival as a vital medicine. Perseus, Cambridge

    Google Scholar 

  • Cambridge English Dictionary. https://dictionary.cambridge.org/dictionary/english. Accessed 18 May 2019

  • Cave A, Kurz X, Arlett P (2019) Real-world data for regulatory decision making: challenges and possible solutions for Europe. Clin Pharmacol Ther 106(1):36–39

    Article  PubMed  PubMed Central  Google Scholar 

  • Charted Institute of Ergonomics & Human Factors (CIEHF). What is ergonomics: find out how it makes life better [webpage]. CIEHF, Birmingham. https://www.ergonomics.org.uk/Public/Resources/What_is_Ergonomics_/Public/Resources/What_is_Ergonomics_.aspx?hkey=2769db3e-4b5b-46c2-864c-dfcf2e44372d. Accessed 2 Sept 2019

  • Cheung K, Ho SMS, Lam W (2017) Factors affecting the willingness of nursing students to receive annual seasonal influenza vaccination: a large-scale cross-sectional study. Vaccine 35:1482–1587

    Article  PubMed  Google Scholar 

  • Ciciriello S, Johnston RV, Osborne RH, Wicks I, deKroo T, Clerehan R, O’Neill C, Buchbinder R (2013) Multimedia educational interventions for consumers about prescribed and over-the-counter medications. Cochrane Database Syst Rev (4):CD008416

    Google Scholar 

  • Cochrane Collaboration [website]. http://www.cochrane.org. Accessed 16 Jun 2018

  • Coulehan J. What is medical humanities and why? Lit Med Magazine. https://medhum.med.nyu.edu/magazine/?p=100. Accessed 11 May 2019

  • Council for International Organizations of Medical Sciences (CIOMS) (1999) Guidelines for preparing core clinical safety information on drugs: report of CIOMS working groups III and V, 2nd edn. CIOMS, Geneva

    Google Scholar 

  • Council for International Organizations of Medical Sciences (CIOMS) (2010) Practical aspects of signal detection in pharmacovigilance: report of CIOMS working group VIII. CIOMS, Geneva

    Google Scholar 

  • Council for International Organizations of Medical Sciences (CIOMS) (2014) Practical approaches to risk minimisation for medicinal product: report of CIOMS working group IX. CIOMS, Geneva

    Google Scholar 

  • Council for International Organizations of Medical Sciences (CIOMS) (2018) CIOMS guide on vaccine safety communication. CIOMS, Geneva. (includes references to regional and global guidance)

    Google Scholar 

  • Council for International Organizations of Medical Sciences (CIOMS), World Health Organization (WHO) (2012) Definition and application of terms of vaccine pharmacovigilance: report of CIOMS/WHO working group on vaccine pharmacovigilance. CIOMS, Geneva

    Google Scholar 

  • Council of Canadian Academies (2015) Health product risk communication: is the message getting through? The Expert Panel on the Effectiveness of Health Product Risk Communication, Council of Canadian Academies, Ottawa

    Google Scholar 

  • Cox AT, Butt TF (2012) Adverse drug reactions: when the risk becomes a reality for patients. Drug Saf 35:977–981

    Article  PubMed  Google Scholar 

  • Daly A (1998) Thalidomide: was the tragedy preventable? Lancet 351:1197–1199

    Article  Google Scholar 

  • Dana Centre (host) (2006) When science hits the headlines [public discussion with panelists: F Mellor (Imperial College London), N Mendoza (science media Centre), J Perry (the sun), D Vaughan (British Antarctic survey)]. Dana Centre, London

    Google Scholar 

  • Dante or Die (1 Mar 2011) Side effects [dance theatre performance]. Trinity Laban Conservatoire of Music and Dance, London. Information on the performance accessible at: http://www.danteordie.com/side_effects.html0. Accessed 29 Dec 2017

  • Dean AJ, Hendy A, McGuire T (2007) Antidepressants in children and adolescents: changes in utilisation after safety warnings. Pharmacoepidemiol Drug Saf 16:1048–1053

    Article  PubMed  Google Scholar 

  • DeFrank JT, McGormack L, West SL, Lefebvre C, Burrus O (2019) Unintended effects of communicating about drug safety issues: a critical review of the literature. Drug Saf 42:1125–1134

    Article  PubMed  Google Scholar 

  • Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C (2012) Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev (2):CD004407

    Google Scholar 

  • Deming WE (1982) Out of the crisis. Massachusetts Institute of Technology, Cambridge

    Google Scholar 

  • Dodoo A, Adjei S, Couper M, Hugman B, Edwards R (2007) When rumours derail a mass deworming exercise. Lancet 370:465–466

    Article  PubMed  Google Scholar 

  • Donabedian A (1966) Evaluating the quality of medical care. Milbank Q 44:166–203

    Article  Google Scholar 

  • Donabedian A (1988) The quality of care: how can it be assessed? J Am Med Assoc 260:1743–1748

    Article  CAS  Google Scholar 

  • Donabedian A (2001) A founder of quality assessment encounters a troubled system first-hand: interview by Fitzhugh Mullan. Health Aff (Millwood) 20:137–141

    Article  CAS  Google Scholar 

  • Douglas J (regional representative of the UN Office on Drugs and Crime (UNODC) to Southeast Asia and the Pacific), Holpuch A (18 Aug 2017) Synthetic opioid crisis in US serves as warning for the world, says UN. Guardian [online news]. https://www.theguardian.com/us-news/2017/aug/18/un-synthetic-opioid-crisis-uk-australia-deaths. Accessed 18 Aug 2017

  • Downs JS (2011) Evaluation (chapter 3). In: Fischhoff B, Brewer NT, Downs JS (eds) Communicating risks and benefits: an evidence-based user’s guide. US Food and Drug Administration, Silver Spring, pp 11–18

    Google Scholar 

  • Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME (2018) A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. Int J Gynaecol Obstet 141(3):287–294

    Article  PubMed  PubMed Central  Google Scholar 

  • Dulicek P, Ivanova E, Kostal M, Sadilek P, Beranek M, Zak P, Hirmerova J (2018) Analysis of risk factors of stroke and venous thromboembolism in females with oral contraceptives use. Clin Appl Thromb Hemost 24(5):797–802

    Article  CAS  PubMed  Google Scholar 

  • Dusetzina SB, Higashi AS, Dorsey ER, Conti R, Huskamp HA, Zhu S, Garfield CF, Alexander GC (2012) Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review. Med Care 50:466–478

    Article  PubMed  PubMed Central  Google Scholar 

  • Edwards B, Chakraborty S (2012) Risk communication and the pharmaceutical industry. Drug Saf 35:1027–1040

    Article  PubMed  Google Scholar 

  • Edwards IR, Lindquist M (2011) Social media and networks in pharmacovigilance: boon or bane. Drug Saf 34:267–271

    Article  PubMed  Google Scholar 

  • Elias C, Fournier A, Vasiliu A, Beix N, Demillac R, Tillaut H, Guillois Y, Eyebe S, Mollo B, Crépey P (2017) Seasonal influenza vaccination coverage and its determinants among nursing homes personnel in western France. BMC Public Health 17:634

    Article  PubMed  PubMed Central  Google Scholar 

  • Encyclopedia of Sociology (2001) Sentiment. https://www.encyclopedia.com/social-sciences/encyclopedias-almanacs-transcripts-and-maps/sentiments. Accessed 30 Dec 2018

  • Erice (2017) A new Erice report considering the safety of medicines in the 21st century (report of a meeting held in Erice, 25–29 September 2016, organised by professor Giampaolo Velo, the International School of Pharmacology at the Ettore Majorana Foundation and Centre for Scientific Culture in Erice, Italy, in collaboration with the Uppsala Monitoring Centre (UMC)). UMC, Uppsala

    Google Scholar 

  • Erice Declaration (1997) Effective communications in pharmacovigilance (report of the international conference on developing effective communications in pharmacovigilance held in Erice, 24–27 September 1997, organised by the Uppsala monitoring Centre (UMC), the clinical pharmacology unit of Verona University, the International School of Pharmacology of the Ettore Majorana Centre for Scientific Culture in Erice, Italy and the World Health Organisation, and supported by EQUUS Communications, London). UMC, Uppsala

    Google Scholar 

  • European Centre for Disease Prevention and Control (ECDC) (2017) Measles [webpage]. ECDC, Stockholm. https://ecdc.europa.eu. Accessed 6 Apr 2019

  • Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT) [website]. European Medicines Agency: PROTECT; 2009–2017. www.imi-protect.eu. Accessed 6 Apr 2019

  • European Medicines Agency (EMA) (2005) European medicines agency finalises review of antidepressants in children and adolescents [media release]. EMA, London

    Google Scholar 

  • European Medicines Agency (EMA) (2008) Assessment report for thalidomide pharmion. EMA, London

    Google Scholar 

  • European Medicines Agency (EMA) (2011) Pandemic report and lessons learned: outcome of the European medicines Agency’s activities during the 2009 (H1N1) flu pandemic. EMA, London

    Google Scholar 

  • European Medicines Agency (EMA) (2013) Combined hormonal contraceptives [webpage]. EMA, London. https://www.ema.europa.eu. Accessed 29 Dec 2017

  • European Medicines Agency (EMA) (2015) EMA-PRAC good practice guide on recording, coding, reporting and assessment of medication errors. EMA, London

    Google Scholar 

  • European Medicines Agency (EMA) (10 Aug 2018a). Update on review of valsartan medicines due to detection of NDMA [press release]. EMA, London. https://www.ema.europa.eu. Accessed 27 Aug 2018

  • European Medicines Agency (EMA) (13 Sept 2018b) Update on review of valsartan medicines: risk from NDMA remains low, a related substance NDEA also being investigated [press release]. EMA, London. https://www.ema.europa.eu. Accessed 3 Sept 2019

  • European Medicines Agency (EMA) (2018c) Valproate and related substances [webpage]. EMA, London. https://www.ema.europa.eu. Accessed 6 Apr 2019

  • European Medicines Agency (EMA), Heads of Medicines Agencies. Guideline on good pharmacovigilance practices (EU-GVP). EMA (2012–2019), London; EMA (2019–), Amsterdam

    Google Scholar 

  • European Medicines Agency (EMA), Heads of Medicines Agencies (2013) Guideline on good pharmacovigilance practices - product- or population-specific considerations I: vaccines for prophylaxis against infectious diseases. EMA, London

    Google Scholar 

  • European Medicines Agency (EMA), Heads of Medicines Agencies (2017) Guideline on good pharmacovigilance practices - module XVI on risk minimisation measures: selection of tools and effectiveness indicators, Rev 2. EMA, London

    Google Scholar 

  • European Medicines Agency (EMA), Heads of Medicines Agencies (9 Oct 2017) Guideline on good pharmacovigilance practices – annex II – templates. Communication Plan for Direct Healthcare Professional Communication (CP DHPC), London (following informal use for a number of years, the template was formalised as regulatory guidance in 2017)

    Google Scholar 

  • European Medicines Agency (EMA), Pharmacovigilance Risk Assessment Committee (PRAC) (30 Nov 2017) PRAC strategy on measuring the impact of pharmacovigilance activities, Rev 1. EMA, London

    Google Scholar 

  • European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) (4 Jul 2018) Guide on methodological standards in pharmacoepidemiology, Rev 7. EMA, London

    Google Scholar 

  • European Union (28 Nov 2004a) Directive 2001/83/EC of the European parliament and of the council of 6 November 2001 on the community code relating to medicinal products for human use as amended. Off J Eur Commun L 311:67–128. Amended by: European Union (31 Dec 2010). Directive 2010/84/EU of the European parliament and of the council of 15 December 2010 amending, as regards pharmacovigilance Directive 2011/83/EC. Off J Eur Commun L 348:74–99, Article 1(2)

    Google Scholar 

  • European Union (28 Nov 2004b) Directive 2001/83/EC of the European parliament and of the council of 6 November 2001 on the community code relating to medicinal products for human use as amended. Off J Eur Commun L 311:67–128. Amended by: European Union (31 Dec 2010) Directive 2010/84/EU of the European parliament and of the council of 15 December 2010 amending, as regards pharmacovigilance Directive 2011/83/EC. Off J Eur Commun L 348:74–99: Article 1(3)

    Google Scholar 

  • Evans M (2002) Reflection on the humanities in medical education. Med Educ 36:508–513

    Article  PubMed  Google Scholar 

  • Evans M, Greaves D (2001) ‘Developing the medical humanities’: report of a research colloquium, and collected abstracts of papers. Med Humanit 27:93–98

    Article  CAS  PubMed  Google Scholar 

  • Fernández-Villa T, Molina AJ, Torner N, Castilla J, Astray J, García-Gutiérrez S, Mayoral JM, Tamames S, Domínguez Á, Martín V, CIBERESP Working Group for the Survey on Influenza Vaccination in Primary Health Care Workers (2017) Factors associated with acceptance of pandemic flu vaccine by healthcare professionals in Spain, 2009–2010. Res Nurs Health 40:435–443

    Article  PubMed  Google Scholar 

  • Finn M, Sarangi S (2009) Humanizing HIV/AIDS and its (re)stigmatizing effects: HIV public ‘positive’ speaking in India. Health (London) 13:47–65

    Article  Google Scholar 

  • Fischhoff B, Brewer NT, Downs JS (eds) (2011) Communicating risks and benefits: an evidence-based user’s guide. US Food and Drug Administration, Silver Spring

    Google Scholar 

  • Freeman S, Critchley D, Lee L (2010) Pharmacopoeia medical-art collaboration. Cradle to grave [art installation]. 2003. Exhibited at: British museum, London. (cradle to grave [epilogue]). In: Wynants M (ed) In sickness and in health: the future of medicine - added value and global access. ASP, Brussels. http://www.pharmacopoeia-art.net/articles/in-sickness-and-in-health/. Accessed 29 Dec 2017

    Google Scholar 

  • Frewer LJ (1999) Public perceptions and risk communication. In: Bennett P, Calman K (eds) Risk communication and public health. Oxford University Press, Oxford, pp 20–32

    Google Scholar 

  • Friedman RA (2014) Antidepressants’ black-box warning: 10 years later. N Engl J Med 371:1666–1668

    Article  PubMed  Google Scholar 

  • GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet 390:1211–1259

    Article  Google Scholar 

  • Giddens A (1998) The third way: the renewal of social democracy. Polity, Blackwell, Cambridge

    Google Scholar 

  • Goedecke T, Morales D, Pacurariu A, Kurz X (2018) Measuring the impact of medicines regulatory interventions: systematic review and methodological considerations. Br J Clin Pharmacol 84:419–433

    Article  PubMed  Google Scholar 

  • Goldacre B (2009) Bad science. Fourth Estate, London

    Google Scholar 

  • Goodman JR (2019) Reliance on emoji may push as back towards cave drawings. Br Med J 364:l264

    Article  Google Scholar 

  • Govender E (2013) Working in the greyzone: exploring education-entertainment in Africa. Afr Commun Res 6:5–32

    Google Scholar 

  • Grainger D, Lead Investigator. EDURANT/EVIPLERA health care professional survey (rilpivirine). The European Union Electronic Register of Post-Authorisation Studies (EU PAS Register), London (EU PAS Register Number EUPAS5565, last updated on 2 Aug 2017). http://www.encepp.eu/encepp/viewResource.htm?id=20230. Accessed 29 Dec 2017

  • Greaves D, Evans M (2000) Medical Humanities. Med Humanit 26:1–2

    Article  CAS  PubMed  Google Scholar 

  • Grilli R, Ramsay C, Minozzi S (2002) Mass media interventions: effects on health services utilisation. Cochrane Database Syst Rev (1):CD000389

    Google Scholar 

  • Grunig JE, National Academies of Sciences, Engineering, and Medicine (2015) Trust and confidence at the interfaces of the life sciences and society: does the public trust science? [workshop summary]. The National Academies Press, Washington, DC, p 7

    Google Scholar 

  • Habib S, Rishpon S, Grotto I, Afek A (2017) Influenza vaccination among healthcare workers: the data and the duty [in Hebrew; abstract in English]. Harefuah 156:4–7

    PubMed  Google Scholar 

  • Hagemeister MH, Stock NK, Ludwig T, Heuschmann P, Vogel U (2018) Self-reported influenza vaccination rates and attitudes towards vaccination among health care workers: results of a survey in a German university hospital. Public Health 154:102–109

    Article  CAS  PubMed  Google Scholar 

  • Hallgreen CE, Mt-Isa S, Lieftucht A, Phillips LD, Hughes D, Talbot S, Asiimwe A, Downey G, Genov G, Hermann R, Noel R, Peters R, Micaleff A, Tzoulaki I, Ashby D, on behalf of PROTECT Benefit-Risk Group (2016) Literature review of visual representation of the results of benefit–risk assessments of medicinal products. Pharmacoepidemiol Drug Saf 25:238–250

    Article  PubMed  Google Scholar 

  • Health and Safety Executive (HSE) (1999) Reducing error and influencing behaviour. HSG48. HSE, London

    Google Scholar 

  • Health Canada (2015) Guide for using the standardized health product risk communication template. Health Canada, Ottawa

    Google Scholar 

  • Health Communication Partnership (HCP) (2003) The new P-process: steps in strategic communication. HCP at Johns Hopkins Bloomberg School of Public Health, Center for Communication Programs, Baltimore

    Google Scholar 

  • Hernandez JF, van Thiel GJMW, Mantel-Teeuwisse AK, Raaijmakers JA, Pieters T (2014) Restoring trust in the pharmaceutical sector on the basis of the SSRI case. Drug Discov Today 19:523–527

    Article  PubMed  Google Scholar 

  • Hickler B (2015) Vaccine special issue on vaccine hesitancy [editorial]. Vaccine 33:4155–4156

    Article  PubMed  Google Scholar 

  • Higgins O, Sixsmith J, Barry MM, Domegan C (2011) A literature review on health information-seeking behaviour on the web: a health consumer and health professional perspective. ECDC, Stockholm

    Google Scholar 

  • Hirst D (1992) Pharmacy [art installation]. Exhibited at: Cohen Gallery, New York, Tate Modern, London. Information on the exhibition in: Manchester E. Damien Hirst, Pharmacy, 1992, 2000, revised 2009. http://www.tate.org.uk/art/artworks/hirst-pharmacy-t07187. Accessed 29 Dec 2017

  • Hotez PJ (2018) Vaccines did not cause Rachel’s autism. Johns Hopkins University Press, Baltimore

    Google Scholar 

  • Hugman B (2009) Healthcare communication. Pharmaceutical Press, London, Chicago

    Google Scholar 

  • Hugon-Rodin J, Horellou MH, Conard J, Flaujac C, Gompel A, Plu-Bureau G, for the COntraception, REcurrent Venous Event (COREVE) investigators (2017a) First venous thromboembolism and hormonal contraceptives in young French women. Medicine (Baltimore) 96:e7734

    Article  CAS  Google Scholar 

  • Hugon-Rodin J, Horellou MH, Conard J, Gompel A, Plu-Bureau G (2017b) Combined hormonal contraceptives and first venous thrombosis in young French women: impact of thrombotic family history. J Endocr Soc 1:762–771

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • ICH Secretariat (2003) International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). ICH-E2D guideline: post-approval safety data management - definitions and standards for expedited reporting. ICH Secretariat, Geneva

    Google Scholar 

  • ICH Secretariat (2010) International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). ICH-E2F guideline: development safety update report. ICH Secretariat, Geneva

    Google Scholar 

  • ICH Secretariat (2013) International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). ICH-E2C (R2) guideline: periodic benefit-risk evaluation report (PBRER). ICH Secretariat, Geneva

    Google Scholar 

  • Illman J (2013) MMR and the media: a historical perspective. Society of Applied Microbiology, London

    Google Scholar 

  • Institute of Development Studies, United Kingdom. Participatory action research [webpage]. https://www.participatorymethods.org/glossary/participatory-action-research. Accessed 30 Mar 2019

  • International Pharmaceutical Federation (FIP) (2017a) Medicines information: strategic development. FIP, The Hague

    Google Scholar 

  • International Pharmaceutical Federation (FIP) (2017b) Pictogram software (last update: 7 February 2017). FIP, Den Haag. https://www.fip.org/pictograms. Accessed 28 Jun 2017

  • International Society for Pharmacoepidemiology (ISPE). Pharmacoepidemiology [definition]. https://www.pharmacoepi.org/about-ispe/overview/. Accessed 11 May 2019

  • Jacobs W, Amuta AO, Jeon KC (2017) Health information seeking in the digital age: an analysis of health information seeking behavior among US adults. Cogent Soc Sci 3:1302785

    Google Scholar 

  • Jamison AM, Broniatowski DA, Quinn SC (2019) Malicious actors on twitter: a guide for public health researchers. Am J Public Health 109:688–692

    Article  PubMed  PubMed Central  Google Scholar 

  • Jarosch J, Allhoff F (2006) Ethics and patient-centered communication. Appendix B to: improving communication-improving care: an ethical force program consensus report. American Medical Association, Chicago

    Google Scholar 

  • Jarret C, Wilson R, O’Leary M, Eckersberger E, Larson HJ, SAGE Working Group on Vaccine Hesitancy (2015) Strategies for addressing vaccine hesitancy: a systematic review. Vaccine 33:4180–4190

    Article  Google Scholar 

  • Johns Hopkins Medical Institutions (JHMI) (24 June 2008) Mendel didn’t have the whole picture: our genome changes over lifetime, Johns Hopkins experts say [media release]. JHMI, Baltimore

    Google Scholar 

  • Jones RH (2013) Health and risk communication: an applied linguistic perspective. Routledge, Abingdon

    Book  Google Scholar 

  • Jordan T (2008) Addition [novel]. Sceptre, London

    Google Scholar 

  • van Mill JWF (ed) (1997–) International journal of clinical pharmacy. Springer, Basel

    Google Scholar 

  • Karafillakis E, Larson H, on behalf of the ADVANCE Consortium (2017) A systematic literature review of perceived risks of vaccines in European populations. Vaccine 35:4840–4850

    Article  PubMed  Google Scholar 

  • Kasperson RE, Renn O, Slovic P, Brown HS, Emel J, Goble R et al (1988) The social amplification of risk: a conceptual framework. Risk Anal 8:177–187

    Article  Google Scholar 

  • Katz LY, Kozyrskyj AL, Prior HJ, Enns MW, Cox BJ, Sareen J (2008) Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. Can Med Assoc J 178:1005–1011

    Article  Google Scholar 

  • Kaufman J, Synnot A, Ryan R, Hill S, Horey D, Willis N, Lin V, Robinson P (2013) Face to face interventions for informing or educating parents about early childhood vaccination. Cochrane Database Syst Rev (5):CD010038

    Google Scholar 

  • Kesselheim AS (2012) Pharmacoepidemiology and the law. In: Strom BL, Kimmel SE, Hennessy S (eds) Pharmacoepidemiology, 5th edn. Wiley, Chichester, pp 117–134

    Chapter  Google Scholar 

  • Kesselheim AS, Campbell EG, Schneeweiss S, Rausch P, Lappin BM, Zhou EH, Seeger JD, Brownstein JS, Woloshin S, Schwartz LM, Toomey T, Dal Pan GJ, Avorn J (2015) Methodological approaches to evaluate the impact of FDA drug safety communications. Drug Saf 38:565–575

    Article  CAS  PubMed  Google Scholar 

  • Kesselheim AS, McGraw AS, Dejene SZ, Rausch P, Dal Pan GJ, Lappin BM, Zhou EH, Avorn J, Campbell EG (2017) Patient and physician perceptions of drug safety information for sleep aids: a qualitative study. Drug Saf 40:531–542

    Article  PubMed  Google Scholar 

  • Kesselheim AS, Sinha MS, Campbell EG, Schneeweiss S, Rausch P, Lappin BM, Zhou EH, Avorn J, Dal Pan GJ (2019) Multimodal analysis of FDA drug safety communications: lessons from zolpidem. Drug Saf 42:1287–1295

    Article  PubMed  Google Scholar 

  • Kholsa S, White R, Medina J, Ouwens M, Emmas C, Koder T, Male G, Leonard S (2018) Real world evidence (RWE): a disruptive innovation or the quiet evolution of medical evidence generation? F1000Res 7:111

    Article  Google Scholar 

  • Kirklin D (2003) The Centre for Medical Humanities, Royal Free and university college medical school, London, England. Acad Med 78:1048–1053

    Article  PubMed  Google Scholar 

  • Ko K, Kim S, Kim SH, Son KY, Lee J, Lee DR (2017) Knowledge, current status, and barriers toward healthcare worker vaccination among family medicine resident participants in a web-based survey in Korea. Korean J Fam Med 38:21–27

    Article  PubMed  PubMed Central  Google Scholar 

  • Kobayashi T, Sugiura K, Ojima T (2017) Risks of thromboembolism associated with hormone contraceptives in Japanese compared with Western women. J Obstet Gynaecol Res 43:789–797

    Article  CAS  PubMed  Google Scholar 

  • Kotler P, Roberto N, Lee N (2002) Social marketing: improving the quality of life. Sage, Thousand Oaks

    Google Scholar 

  • Lancet (eds) (2010) Retraction: ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 375:445. (retraction of: Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637–741)

    Article  Google Scholar 

  • Lancet (eds) (2017) Untangling the web of opioid addictions in the USA. Lancet 389:2443

    Article  Google Scholar 

  • Lancet Respiratory Medicine (eds) (2018) Fake medicines: fighting on all fronts. Lancet Respir Med 6:315

    Article  Google Scholar 

  • Larivée N, Suissa S, Coulombe J, Tagalakis V, Filion KB (2017a) Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: an assessment of risk in first-time users and restarters. Drug Saf 40:583–596

    Article  PubMed  CAS  Google Scholar 

  • Larivée N, Suissa S, Khosrow-Khavar F, Tagalakis V, Filion KB (2017b) Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies. BJOG 124:1490–1499

    Article  PubMed  CAS  Google Scholar 

  • Larson HJ, Brocard P, Garnett G (2010) The India HPV-vaccine suspension. Lancet 376:572–573

    Article  PubMed  Google Scholar 

  • Larson HJ, Smith DMD, Paterson P, Cumming M, Eckersberger E, Freifeld CC, Ghinai I, Jarrett C, Paushter L, Brownstein JS, Madoff LC (2013) Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines. Lancet Infect Dis 13:606–613

    Article  PubMed  Google Scholar 

  • Larson HJ, Karafillakis E, Yiangou A, Bahri P, Fogd J, Kurz J, Świerzewski R, Bauchau V, Derrough T, Plebani B, Nohynek H, Mollema L, Sturkenboom M, Myint T-T H, Perez Gomez J, ADVANCE Consortium (4 Oct 2017) Developing communication strategies on vaccine benefits and risks: Guidance for public-private collaborations. Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE). http://www.advance-vaccines.eu. Accessed 29 Dec 2017

  • Lazer DMJ, Baum MA, Benkler Y, Berinsky AJ, Greenhill KM, Menczer F, Metzger MJ, Nyhan B, Pennycook G, Rothschild D, Schudson M, Sloman SA, Sunstein CR, Thorson EA, Watts DJ, Zittrain JL (2018) The science of fake news: addressing fake news requires a multidisciplinary effort. Science 359:1094–1096

    Article  CAS  PubMed  Google Scholar 

  • Légaré F, Stacey D, Turcotte S, Cossi MJ, Kryworuchko J, Graham ID, Lyddiatt A, Politi MC, Thomson R, Elwyn G, Donner-Banzhoff N (2014) Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Database Syst Rev (9):CD006732

    Google Scholar 

  • Littlejohn SW, Foss KA, Oetzel JG (2016) Theories of human communication, 11th edn. Long Grove, Waveland

    Google Scholar 

  • Löfstedt RE (2005) Risk management in post-trust societies. Palgrave Macmillan, New York

    Book  Google Scholar 

  • Löfstedt RE (2007) The impact of the cox-2 inhibitor issue on perceptions of the pharmaceutical industry: content analysis and communication implications. J Health Commun 12:471–491

    Article  PubMed  Google Scholar 

  • Looijmans-van den Akker I, van Delden JJ, Verheij TJ, van Essen GA, van der Sande MA, Hulscher ME, Hak E (2009) Which determinants should be targeted to increase influenza vaccination uptake among health care workers in nursing homes? Vaccine 27:4724–4730

    Article  CAS  PubMed  Google Scholar 

  • Lu CY, Zhang F, Lakoma MD, Madden JM, Rusinak D, Penfold RB, Simon G, Ahmedani BK, Clarke G, Hunkeler EM, Waitzfelder B, Owen-Smith A, Raebel MA, Rossom R, Coleman KJ, Copeland LA, Soumerai SB (2014) Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study. Br Med J 348:g3596

    Article  CAS  Google Scholar 

  • Maasen S, Weingart P (eds) (2006) Democratization of expertise?: exploring novel forms of scientific advice in political decision-making. Springer, Dordrecht

    Google Scholar 

  • MacDonald NE, SAGE Working Group of Vaccine Hesitancy (2015) Vaccine hesitancy: definition, scope and determinants. Vaccine 33:4161–4164

    Article  PubMed  Google Scholar 

  • Maridor M, Ruch S, Bangerter A, Emery V (2017) Skepticism toward emerging infectious diseases and influenza vaccination intentions in nurses. J Health Commun 22:386–394

    Article  PubMed  Google Scholar 

  • Marshall E, Salmon D, Bousfiha N, Togola Y, Ouedraogo F, Santantonio M, Dieng CK, Tartière S, Emmanuelli X (2017) Vaccination coverage among social and healthcare workers in ten countries of Samu-social international sites. Vaccine 35:5291–5296

    Article  PubMed  Google Scholar 

  • Mass YS (2017) Lawmaker urges World Health Organization to stop ‘aggressive’ opioid marketing overseas. masslive.com

  • Mazzaglia G, Straus SMJ, Arlett P, da Silva D, Janssen H, Raine J, Alteri E (2018) Study design and evaluation of risk minimization measures: a review of studies submitted to the European medicines agency for cardiovascular, endocrinology, and metabolic drugs. Drug Saf 41:191–202

    Article  PubMed  Google Scholar 

  • McDaid A, Logette E, Buchillier V, Muriset M, Suchon P, Pache TD, Tanackovic G, Kutalik Z, Michaud J (2017) Risk prediction of developing venous thrombosis in combined oral contraceptive users. PLoS One 12:e0182041

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • McGreal C (13 Aug 2017) Don’t blame addicts for America’s opioid crisis: here are the real culprits. The Guardian [online news]. https://www.theguardian.com. Accessed 13 Aug 2017

  • McKee C, Bohannon K (2016) Exploring the reasons behind parental refusal of vaccines: brief review article. J Pediatr Pharmacol Ther 21:104–109

    PubMed  PubMed Central  Google Scholar 

  • McLuhan M (1964) Understanding media: the extensions of man. Routledge, London, New York

    Google Scholar 

  • Meldrun ML, Tsao JC-I, Zeltzer LK (2009) “I can’t be what I want to be”: children’s narratives of chronic pain experiences and treatment outcomes. Pain Med 10:1018–1034

    Article  Google Scholar 

  • Merriam-Webster Dictionary. https://www.merriam-webster.com. Accessed 29 Dec 2017

  • Minister of Health, Canada (2006) Strategic risk communications framework and handbook. Minister of Health, Canada, Ottawa

    Google Scholar 

  • Ministry of Health, Labour and Welfare (MHLW) (2006) Q&A on early post-marketing phase vigilance for prescription drugs. MHLW, Tokyo

    Google Scholar 

  • Ministry of Health, Labour and Welfare (MHLW) (2009) Q&A on use-results surveys conducted as all-case surveillance and early post-marketing phase vigilance (EPPV) for prescription drugs. PMDA, Tokyo

    Google Scholar 

  • Morgan MG, Fischhoff B, Bostrom A, Atman CJ (2002) Risk communication: a mental models approach. Cambridge University Press, Cambridge

    Google Scholar 

  • Murthy VH (2016) Ending the opioid epidemic: a call to action. N Engl J Med 375:2413–2415

    Article  PubMed  Google Scholar 

  • Mustafa M, Al-Khal A, Maslamani M, Al Soub H (2017) Improving influenza vaccination rates of healthcare workers: a multipronged approach in Qatar. East Mediterr Health J 23:303–310

    Article  PubMed  Google Scholar 

  • National Center for Human Factors in Healthcare (n.d.) What is human factors in healthcare? [webpage]. Washington, DC: National Center for Human Factors in Healthcare

    Google Scholar 

  • National Health Service (NHS) Childhood vaccination coverage statistics, England, 2016–2017 [webpage]. https://digital.nhs.uk. Accessed 1 May 2018

  • New England Journal of Medicine (NEJM) Catalyst (2017) What is patient-centred care? NEJM Catalyst. https://catalyst.nejm.org/what-is-patient-centered-care/. Accessed 1 May 2018

  • Nicolson DJ, Knapp P, Raynor DK, Spoor P (2009) Written information about individual medicines for consumers. Cochrane Database Syst Rev (2):CD002104

    Google Scholar 

  • Nilsen P (2015) Making sense of implementation theories, models and frameworks. Implement Sci 10:53

    Article  PubMed  PubMed Central  Google Scholar 

  • Nilsen ES, Myrhaug HT, Johansen M, Oliver S, Oxman AD (2006) Methods of consumer involvement in developing healthcare policy and research, clinical practice guidelines and patient information material. Cochrane Database Syst Rev (3):CD004563

    Google Scholar 

  • O’Reilly-Shah VN, Lynde GC, Jabaley CS (2018) Is it time to start using emoji in biomedical literature? Br Med J 363:k5033. Online comments accessible at https://www.bmj.com. Accessed 6 Jun 2019

    Article  Google Scholar 

  • O’Sullivan GA, Yonkler JA, Morgan W, Merritt AP (2003) A field guide to designing a health communication strategy. Johns Hopkins Bloomberg School of Public Health, Center for Communication Programs, Baltimore

    Google Scholar 

  • Olsson S, Pal SN, Dodoo A (2015) Pharmacovigilance in resource-limited countries. Expert Rev Clin Pharmacol 8:449–460

    Article  CAS  PubMed  Google Scholar 

  • Organisation for Economic Co-operation and Development (OECD) (2019) Addressing problematic opioid use in OECD countries. OECD, Paris

    Google Scholar 

  • Oxford Dictionary. https://en.oxforddictionaries.com. Accessed 29 Dec 2017

  • Pang A (2013) Dealing with external stakeholders during the crisis: managing the information vacuum. In: DuBrin AJ (ed) Handbook of research on crisis leadership in organizations. Elgar, Cheltenham, pp 209–230

    Chapter  Google Scholar 

  • Penfield K, Bahri P. Kommunikation zwischen Patient und Apotheker: Trainingsvorschlag basierend auf der Bewegungsanalyse nach Laban [workshop abstract]. Hamburg: 22. Norddeutscher Zytostatikaworkshop (NZW); 24–26 January 2014

    Google Scholar 

  • Pharmaceutical Group of European Union (PGEU) (2017) PGEU best practice paper: pharmacovigilance and risk minimisation. PGEU, Brussels

    Google Scholar 

  • Piening S, Haaijer-Ruskamp FM, de Vries JTN, van der Elst ME, de Graeff PA, Straus SMJM, Mol PGM (2012) Impact of safety-related regulatory action on clinical practice: a systematic review. Drug Saf 35:373–385

    Article  PubMed  Google Scholar 

  • Practice Committee of the American Society for Reproductive Medicine (2017) Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Fertil Steril 107:43–51

    Article  CAS  Google Scholar 

  • Rabensteiner A, Buja A, Regele D, Fischer M, Baldo V (2018) Healthcare worker’s attitude to seasonal influenza vaccination in the South Tyrolean province of Italy: barriers and facilitators. Vaccine 36:535–544

    Article  PubMed  Google Scholar 

  • Radawski C, Morrato E, Hornbuckle K, Bahri P, Smith M, Juhaeri J, Mol P, Levitan B, Huang H-Y, Coplan P, Li H, on behalf of the ISPE BRACE SIG (2015) Benefit-risk assessment, communication and evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist. Pharmacoepidemiol Drug Saf 24:1233–1240

    Article  PubMed  Google Scholar 

  • Raine J, Wise L, Blackburn S, Eichler HG, Breckenridge A (2011) European perspective on risk management and drug safety. Clin Pharmacol Therapeutics 89:650–654

    Article  CAS  Google Scholar 

  • Renn O (2015) Stakeholder and public involvement in risk governance. Int J Disaster Risk Sci 6:8–20

    Article  Google Scholar 

  • Renn O, Levine D (1991) Credibility and trust in risk communication. In: Kasperson R, Stallen P (eds) Communicating risks to the public. Kluwer Academic Publishers, Boston, pp 175–218

    Chapter  Google Scholar 

  • Riedel G (2017) Influenza vaccination of healthcare personnel by work setting and occupation [in Spanish]. Rev Chil Infectol 34:294 (abstract in English)

    Article  Google Scholar 

  • Rimon JG (2007) Strategic communication in public health [lecture at training course “leadership in strategic health communication”]. Johns Hopkins Bloomberg School of Public Health, Center for Communication Programs, Baltimore

    Google Scholar 

  • Rolfe A, Cash-Gibson L, Car J, Sheikh A, McKinstry B (2014) Interventions for improving patients’ trust in doctors and groups of doctors. Cochrane Database Syst Rev (3):CD004134

    Google Scholar 

  • Ropeik D (15 Dec 2002) Journalists can be seduced by aspects of risk. Nieman Reports

    Google Scholar 

  • Rosenbaum L (2017) The march of science: the true story. N Engl J Med 377:188–191

    Article  PubMed  Google Scholar 

  • Ryan M, Bate A, Eastmond CJ, Ludbrook A (2001) Use of discrete choice experiments to elicit preferences. Qual Health Care 10(Suppl I):i55–i60

    Article  PubMed  PubMed Central  Google Scholar 

  • Ryan R, Santesso N, Lowe D, Hill S, Grimshaw JM, Prictor M, Kaufman C, Cowie G, Taylor M (2014) Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews. Cochrane Database Syst Rev (4):CD007768

    Google Scholar 

  • Saeterdal I, Lewin S, Austvoll-Dahlgren A, Glenton C, Munabi-Babigumira S (2014) Interventions aimed at communities to inform and/or educate about early childhood vaccination. Cochrane Database Syst Rev (11):CD010232

    Google Scholar 

  • Salisbury D, Council for International Organizations of Medical Sciences (CIOMS) (2018) CIOMS guide on vaccine safety communication. CIOMS, Geneva

    Google Scholar 

  • Schwartz JL (2012) New media, old messages: themes in the history of vaccine hesitancy and refusal. Virtual Mentor 14:50–55

    PubMed  Google Scholar 

  • Schwarz N, Bohner G (2001) The construction of attitudes. In: Tesser A, Schwarz N (eds) Intrapersonal processes (Blackwell handbook of social psychology). Blackwell, Oxford, pp 436–457

    Google Scholar 

  • Schwitzer G (2008) How do US journalists cover treatments, tests, products, and procedures?: an evaluation of 500 stories. PLoS Med 5:e95

    Article  PubMed  PubMed Central  Google Scholar 

  • Schwitzer G, Mudur G, Henry D, Wilson A, Goozner M, Simbra M, Sweet M, Baverstock KA (2005) What are the roles and responsibilities of the media in disseminating health information? PLoS Med 2(7):e215

    Article  PubMed  PubMed Central  Google Scholar 

  • Shankar PR (2014) Medical humanities. Ann Commun Health 2:18–20

    Google Scholar 

  • Shaw SE, Bailey J (2009) Discourse analysis: what is it and why is it relevant to family practice? Fam Pract 26:413–419

    Article  PubMed  Google Scholar 

  • Sinha MS, Freifeld CC, Brownstein JS, Donneyong MM, Rausch P, Lappin BM, Zhou EH, Dal Pan GJ, Pawar AM, Hwang TJ, Avorn J, Kesselheim AS (2018) Social media impact of the Food and Drug Administration’s drug safety communication messaging about zolpidem: mixed-methods analysis. JMIR Public Health Surveill 4:e1

    Article  PubMed  PubMed Central  Google Scholar 

  • Slovic P (2010) The feeling of risk: new perspectives on risk perception. Earthscan, London, Washington, DC

    Google Scholar 

  • Smith MY, Russel A, Bahri P, Mol PGM, Frise S, Freeman E, Morrato EH (2018) The RIMES statement: a checklist to assess the quality of studies evaluating risk minimization programs for medicinal products. Drug Saf 41:389–401

    Article  PubMed  Google Scholar 

  • Soderbergh S (director), Burns SZ (screenplay writer) (2013) Side effects [movie website]. http://sideeffectsmayvary.com. Accessed 29 Dec 2017

  • Soumerai SB. In: Gallaghar J (19 June 2014) Antidepressant suicide warnings ‘may have backfired’. BBC [online news]. http://www.bbc.co.uk/news/health-27904749. Accessed 23 Jun 2014

  • Soumerai SB, Avron J (1990) Principles of educational outreach (“academic detailing”) to improve clinical decision making. J Am Med Assoc 263:549–556

    Article  CAS  Google Scholar 

  • Speers T, Lewis J (2004) Journalists and jabs: media coverage of the MMR vaccine. Commun Med 1:171–181

    Article  PubMed  Google Scholar 

  • Spiewak M (23 Aug 2017) Forscherfeindlichkeit? Autoritätsverlust? Unsinn!: Der deutschen Wissenschaft geht es so gut wie nie zuvor. Zeit [online news]. http://www.zeit.de/2017/35/deutsche-wissenschaft-forschung-studien/komplettansicht. Accessed 23 Aug 2017

  • Spitzer WO (1991) Drugs as determinants of health and disease in the population: an orientation to the bridge science of pharmacoepidemiology. J Clin Epidemiol 44:823–830

    Article  CAS  PubMed  Google Scholar 

  • Squiers L, Peinado S, Berkman N, Boudewyns V, McCormack L (2012) The health literacy skills framework. J Health Comm 17:30–54

    Article  Google Scholar 

  • Stacey D, Légaré F, Col NF, Bennett CL, Barry MJ, Eden KB, Wu JH (2014) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (1):CD001431

    Google Scholar 

  • Stone MB (2014) The FDA warning on antidepressants and suicidality: why the controversy? N Engl J Med 371:1668–1671

    Article  PubMed  Google Scholar 

  • Storey D, Figueroa ME (2012) Toward a global theory of health behaviour and social change. In: Obregon R, Waisbord S (eds) The handbook of global health communication. Wiley-Blackwell, Oxford, pp 70–94

    Chapter  Google Scholar 

  • Sturm L, Donahue K, Kasting M, Kulkarni A, Brewer NT, Zimet GD (2017) Pediatrician-parent conversations about human papillomavirus vaccination: an analysis of audio recordings. J Ado Health 61:246–251

    Article  Google Scholar 

  • Taylor BJ, Killick C, McGlade A (2015) Understanding and using research in social work. Sage, London

    Book  Google Scholar 

  • Thom DH, Ribisl KM, Stewart AL, Luke DA (1999) Further validation and reliability testing of the Trust in Physician Scale. The Stanford trust study physicians. Med Care 37:510–517

    Article  CAS  PubMed  Google Scholar 

  • TIMSS & PIRLS International Study Centre. PIRLS 2016 International study results in reading. http://timssandpirls.bc.edu. Accessed 8 Jun 2019

  • Trevena LJ, Davey HM, Barratt A, Butow P, Caldwell P (2004) A systematic review on communicating with patients about evidence. J Eval Clin Pract 12:13–23

    Article  Google Scholar 

  • Tsintis P, La Mache E (2004) CIOMS and ICH initiatives in pharmacovigilance and risk management: overview and implications. Drug Saf 27:509–517

    Article  PubMed  Google Scholar 

  • Tsukahara VHB, Calil SJ (2016) Root cause analysis combined with human factors engineering tools for adverse events investigation in healthcare. In: Kyriacou E, Christofides S, Pattichis C (eds) XIV Mediterranean conference on medical and biological engineering and computing 2016 (IFMBE proceedings), vol 57. Springer, Basel

    Google Scholar 

  • United Nations (UN) Commission on Life-Saving Commodities (2012) Commissioners’ report. UN, New York

    Google Scholar 

  • United Nations Children’s Fund (UNICEF). What are the social ecological model (SEM), and communication for development (C4D)? UNICEF, New York. https://www.unicef.org/cbsc/files/Module_1_SEM-C4D.docx. Accessed 30 Jul 2017

  • United States Centers of Disease Control (US CDC) (2019) Measles: cases and outbreaks [webpage]. US CDC, Atlanta. https://www.cdc.gov. Accessed 6 Apr 2019

  • United States Food and Drug Administration (US FDA). FDA approved drug products: Thalomid [webpage] (updated in January 2017a). US FDA, Silver Spring. https://www.fda.gov. Accessed 29 Dec 2017

  • United States Food and Drug Administration (US FDA) (2017b) Use of real-world evidence to support regulatory decision-making for medical devices: guidance for Industry and Food and Drug Administration staff. US FDA, Silver Spring

    Google Scholar 

  • United States Food and Drug Administration (US FDA). FDA updates on valsartan recalls. https://www.fda.gov/Drugs/DrugSafety/ucm613916.htm. Accessed 27 Aug 2018a

  • United States Food and Drug Administration (US FDA) (26 Jan 2018b) What’s in a REMS? [webpage]. US FDA, Silver Spring. https://www.fda.gov. Accessed 1 May 2018

  • United States Food and Drug Administration (US FDA) Class suicidality labeling language for antidepressants. US FDA, Silver Spring. https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/20031s045,20936s020lbl.pdf. Accessed 4 Mar 2018c

  • United States Food and Drug Administration (US FDA) (27 Sept 2018d) Precision medicine [webpage]. US FDA, Silver Spring. https://www.fda.gov. Accessed 12 May 2019

  • Uppsala Monitoring Centre (UMC) (15 Mar 2018) Glossary of pharmacovigilance terms. UMC, Uppsala. https://www.who-umc.org. Accessed 1 May 2018

  • van Amsterdam J, van den Brink W (2015) The misuse of prescription opioids: a threat for Europe? Curr Drug Abuse Rev 8:3–14

    Article  PubMed  Google Scholar 

  • Velo G (2010) Erice statement 2009: communication, medicines and patient safety (report of the workshop on drug risk communication held in Erice, 3-8 July 2009, organised by the International School of Pharmacology at the Ettore Majorana Foundation and Centre for Scientific Culture in Erice, Italy, in collaboration with the International Society of Pharmacovigilance (ISoP), the SK Foundation and the Uppsala Monitoring Centre (UMC)). Br J Clin Pharmacol 69:207–208

    Article  Google Scholar 

  • Venkatraman A, Garg N, Kumar N (2015) Greater freedom of speech on web 2.0 correlates with dominance of views linking vaccines to autism. Vaccine 33:1422–1425

    Article  PubMed  Google Scholar 

  • Venulet J, Helling-Borda M (2010) WHO’s international drug monitoring: the formative years, 1967-1975. Drug Saf 33:e1–e23

    Article  PubMed  Google Scholar 

  • Vicusi WK (1994) Efficacy of labeling of foods and pharmaceuticals. Annu Rev Public Health 15:325–343

    Article  Google Scholar 

  • Vollman AR, Anderson ET, McFarlane J (2004) Canadian community as partner. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  • Vosoughi S, Roy D, Aral S (2018) The spread of true and false news online. Science 359:1146–1151

    Article  CAS  PubMed  Google Scholar 

  • Vrije Universiteit Amsterdam (VU). Neuropsychology [master’s degree webpage]. VU, Amsterdam. https://masters.vu.nl/en/programmes/cognitive-neuropsychology/index.aspxrrd. Accessed 11 May 2019

  • Waisbord S. Watchdog journalism. Wiley Online Library. https://onlinelibrary.wiley.com/doi/pdf/10.1002/9781118541555.wbiepc046. Accessed 5 Jun 2019

  • Waller P, Harrison-Woolrych M (2017) An introduction to pharmacovigilance, 2nd edn. Wiley Blackwell, Chichester

    Book  Google Scholar 

  • Waller PC, Evans SJW, Beard K (2005) Drug safety and the media. Br J Clin Pharmacol 61(2):123–126

    Article  PubMed Central  Google Scholar 

  • Way D, Blazsin H, Löfstedt R, Bouder F (2017) Pharmaceutical benefit-risk communication tools: a review of the literature. Drug Saf 40:15–36

    Article  CAS  PubMed  Google Scholar 

  • West SL, Squiers LB, McCormack L, Southwell BG, Brouwer ES, Ashok M, Lux L, Boudewyns V, O’Donoghue A, Sullivan HW (2013) Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising. Pharmacoepidemiol Drug Saf 22:447–458

    Article  PubMed  Google Scholar 

  • Wikipedia. Wit (film) (director: Mike Nichols; play writer: Margaret Edson). Edited on: 7 May 2018a. https://en.wikipedia.org/wiki/Wit_(film). Accessed 1 Jun 2018

  • Wikipedia. BPM (film) (director: Robin Campillo; co-screenwriter: Philippe Mangeot). Edited on: 27 May 2018b. https://en.wikipedia.org/wiki/BPM_(Beats_per_Minute). Accessed on: 1 June 2018

  • Williams J. Strategy development for communication development [lecture]. Baltimore, MD; 12 June 2007 (the lecture was part of the training course “Leadership in Strategic Health Communication” provided by Johns Hopkins Bloomberg School of Public Health, Center for Communication Programs in Baltimore, MD: 4–22 June 2007)

    Google Scholar 

  • Woloshin S, Schwartz LM, Dejene S, Rausch P, Dal Pan GJ, Zhou EH, Kesselheim AS (2017) Media coverage of FDA drug safety communications about zolpidem: a quantitative and qualitative analysis. J Health Commun 22:365–372

    Article  PubMed  Google Scholar 

  • World Health Organization (WHO) (2002) The importance of pharmacovigilance: safety monitoring of medicinal products. WHO, Geneva

    Google Scholar 

  • World Health Organization (WHO) (2009) Human factors in patient safety: review of topics and tools. WHO, Geneva

    Google Scholar 

  • World Health Organization (WHO) (2014) EMP thalidomide is back: are we ready for it? [news release]. WHO, Geneva

    Google Scholar 

  • World Health Organization (WHO) (2014–2017) Community engagement in the Ebola response [webpage]. WHO, Geneva. http://www.who.int. Accessed 29 Dec 2017

  • World Health Organization (WHO) (2015) Global action plan on antimicrobial resistance. WHO, Geneva

    Google Scholar 

  • World Health Organization (WHO) (2016a) Final trial results confirm Ebola vaccine provides high protection against disease [news release]. WHO, Geneva

    Google Scholar 

  • World Health Organization (WHO) (2016b) Antimicrobial resistance [fact sheet]. WHO, Geneva

    Google Scholar 

  • World Health Organization (WHO) (2017a) Leprosy [fact sheet]. WHO, Geneva

    Google Scholar 

  • World Health Organization (WHO) (2017b) MMR and autism [webpage]. WHO, Geneva. http://www.who.int. Accessed 29 Dec 2017

    Google Scholar 

  • World Health Organization (WHO) (2017c) Measles [fact sheet]. WHO, Geneva

    Google Scholar 

  • World Health Organization (WHO) (2017d) Mental health [webpage]. WHO, Geneva. http://www.who.int. Accessed 29 Dec 2017

    Google Scholar 

  • World Health Organization (WHO) (2017e) Depression [fact sheet]. WHO, Geneva

    Google Scholar 

Download references

Declarations

The views expressed in this chapter are the author’s personal views and may not be understood or quoted as being made on behalf of or reflecting the position of her employing organisation, i.e. the European Medicines Agency (EMA), or any of its committees or working parties. The work on this chapter and as editor of the whole book was undertaken in the author’s free time outside EMA working hours, in accordance with the EMA policy on external activities. The author has not gained any profit from writing for this book and will not gain money through its sales.

Author information

Authors and Affiliations

  1. European Medicines Agency (EMA), Amsterdam, The Netherlands

    Priya Bahri

Authors
  1. Priya Bahri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Priya Bahri .

Editor information

Editors and Affiliations

  1. European Medicines Agency (EMA), Amsterdam, Noord-Holland, The Netherlands

    Priya Bahri

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bahri, P. (2020). A Multilayered Research Framework for Humanities and Epidemiology of Medicinal Product Risk Communication. In: Bahri, P. (eds) Communicating about Risks and Safe Use of Medicines. Adis, Singapore. https://doi.org/10.1007/978-981-15-3013-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-3013-5_1

  • Published:

  • Publisher Name: Adis, Singapore

  • Print ISBN: 978-981-15-3012-8

  • Online ISBN: 978-981-15-3013-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation